Logo image of ABLD.PA

ABL DIAGNOSTICS (ABLD.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ABLD - FR001400AHX6 - Common Stock

3.1 EUR
+0.04 (+1.31%)
Last: 12/16/2025, 7:00:00 PM
Fundamental Rating

4

ABLD gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 19 industry peers in the Trading Companies & Distributors industry. While ABLD seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ABLD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ABLD was profitable.
ABLD had positive earnings in 4 of the past 5 years.
ABLD had negative operating cash flow in 4 of the past 5 years.
ABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.17%, ABLD is in line with its industry, outperforming 52.63% of the companies in the same industry.
ABLD has a Return On Equity (6.69%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 4.17%
ROE 6.69%
ROIC N/A
ROA(3y)3.32%
ROA(5y)3.14%
ROE(3y)6.99%
ROE(5y)5.41%
ROIC(3y)N/A
ROIC(5y)N/A
ABLD.PA Yearly ROA, ROE, ROICABLD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

ABLD's Profit Margin of 8.51% is fine compared to the rest of the industry. ABLD outperforms 78.95% of its industry peers.
ABLD does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 8.51%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABLD.PA Yearly Profit, Operating, Gross MarginsABLD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400

6

2. Health

2.1 Basic Checks

ABLD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ABLD remains at a similar level compared to 1 year ago.
ABLD has more shares outstanding than it did 5 years ago.
ABLD has a better debt/assets ratio than last year.
ABLD.PA Yearly Shares OutstandingABLD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ABLD.PA Yearly Total Debt VS Total AssetsABLD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

An Altman-Z score of 8.25 indicates that ABLD is not in any danger for bankruptcy at the moment.
ABLD has a better Altman-Z score (8.25) than 89.47% of its industry peers.
ABLD has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ABLD (0.26) is better than 73.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 8.25
ROIC/WACCN/A
WACC7.83%
ABLD.PA Yearly LT Debt VS Equity VS FCFABLD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

ABLD has a Current Ratio of 3.26. This indicates that ABLD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.26, ABLD belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
A Quick Ratio of 2.91 indicates that ABLD has no problem at all paying its short term obligations.
ABLD has a better Quick ratio (2.91) than 94.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3.26
Quick Ratio 2.91
ABLD.PA Yearly Current Assets VS Current LiabilitesABLD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 150.43% over the past year.
The earnings per share for ABLD have been decreasing by -48.36% on average. This is quite bad
The Revenue has decreased by -7.68% in the past year.
EPS 1Y (TTM)150.43%
EPS 3Y-48.36%
EPS 5YN/A
EPS Q2Q%160.87%
Revenue 1Y (TTM)-7.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.32%

3.2 Future

Based on estimates for the next years, ABLD will show a very strong growth in Earnings Per Share. The EPS will grow by 41.42% on average per year.
The Revenue is expected to grow by 41.75% on average over the next years. This is a very strong growth
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.37%
Revenue Next 2Y41.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
ABLD.PA Yearly Revenue VS EstimatesABLD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
ABLD.PA Yearly EPS VS EstimatesABLD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.02 0.04 0.06

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 103.33, the valuation of ABLD can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ABLD indicates a slightly more expensive valuation: ABLD is more expensive than 78.95% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ABLD to the average of the S&P500 Index (26.43), we can say ABLD is valued expensively.
The Price/Forward Earnings ratio is 50.65, which means the current valuation is very expensive for ABLD.
Based on the Price/Forward Earnings ratio, ABLD is valued a bit more expensive than 78.95% of the companies in the same industry.
ABLD is valuated expensively when we compare the Price/Forward Earnings ratio to 23.66, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 103.33
Fwd PE 50.65
ABLD.PA Price Earnings VS Forward Price EarningsABLD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABLD.PA Per share dataABLD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

ABLD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ABLD's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)1.03
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

ABLD has a Yearly Dividend Yield of 1.48%. Purely for dividend investing, there may be better candidates out there.
The stock price of ABLD dropped by -29.55% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
ABLD's Dividend Yield is slightly below the industry average, which is at 2.18.
ABLD's Dividend Yield is slightly below the S&P500 average, which is at 1.87.
Industry RankSector Rank
Dividend Yield 1.48%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABLD.PA Yearly Dividends per shareABLD.PA Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04

5.3 Sustainability

DPN/A
EPS Next 2Y41.42%
EPS Next 3YN/A
ABLD.PA Yearly Income VS Free CF VS DividendABLD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M

ABL DIAGNOSTICS

EPA:ABLD (12/16/2025, 7:00:00 PM)

3.1

+0.04 (+1.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners99.24%
Ins Owner ChangeN/A
Market Cap49.94M
Revenue(TTM)5.45M
Net Income(TTM)463.40K
Analysts85.71
Price Target6.28 (102.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.48%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 103.33
Fwd PE 50.65
P/S 9.17
P/FCF N/A
P/OCF N/A
P/B 7.21
P/tB 11.97
EV/EBITDA N/A
EPS(TTM)0.03
EY0.97%
EPS(NY)0.06
Fwd EY1.97%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.34
BVpS0.43
TBVpS0.26
PEG (NY)1.03
PEG (5Y)N/A
Graham Number0.54
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 6.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 8.51%
GM N/A
FCFM N/A
ROA(3y)3.32%
ROA(5y)3.14%
ROE(3y)6.99%
ROE(5y)5.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.26
Quick Ratio 2.91
Altman-Z 8.25
F-ScoreN/A
WACC7.83%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150.43%
EPS 3Y-48.36%
EPS 5YN/A
EPS Q2Q%160.87%
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.32%
Revenue Next Year34.37%
Revenue Next 2Y41.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year789.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ABL DIAGNOSTICS / ABLD.PA FAQ

What is the ChartMill fundamental rating of ABL DIAGNOSTICS (ABLD.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ABLD.PA.


What is the valuation status for ABLD stock?

ChartMill assigns a valuation rating of 1 / 10 to ABL DIAGNOSTICS (ABLD.PA). This can be considered as Overvalued.


What is the profitability of ABLD stock?

ABL DIAGNOSTICS (ABLD.PA) has a profitability rating of 2 / 10.


What is the financial health of ABL DIAGNOSTICS (ABLD.PA) stock?

The financial health rating of ABL DIAGNOSTICS (ABLD.PA) is 6 / 10.


What is the earnings growth outlook for ABL DIAGNOSTICS?

The Earnings per Share (EPS) of ABL DIAGNOSTICS (ABLD.PA) is expected to grow by 100% in the next year.